Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.442 SEK | -3.49% | +13.33% | -49.77% |
Mar. 27 | Biosergen Raises SEK26.4 Million via Rights Issue | MT |
Feb. 29 | Biosergen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | 257M 24.1M | Capitalization | 61.23M 5.73M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net Debt 2024 * | 63.1M 5.91M | Net Debt 2025 * | 288M 26.95M | EV / Sales 2025 * | 1.36 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 3 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.89% |
1 day | -3.49% | ||
1 week | +13.33% | ||
Current month | -40.27% | ||
1 month | -40.67% | ||
3 months | -50.61% | ||
6 months | -64.64% | ||
Current year | -49.77% |
Managers | Title | Age | Since |
---|---|---|---|
Tine Kold Olesen
CEO | Chief Executive Officer | - | - |
Niels Laursen
DFI | Director of Finance/CFO | 68 | - |
Chief Tech/Sci/R&D Officer | 72 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-12-31 | |
Achim Kaufhold
BRD | Director/Board Member | 66 | 20-12-31 |
Chairman | 65 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.442 | -3.49% | 6,793 |
24-03-27 | 0.458 | +3.15% | 51,126 |
24-03-26 | 0.444 | -5.93% | 73,769 |
24-03-25 | 0.472 | -3.28% | 57,538 |
24-03-22 | 0.488 | +25.13% | 169,629 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 06:44 am EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.77% | 5.73M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |